Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Raw Materials: 2023-2025

Historic Raw Materials for SRx Health Solutions (SRXH) over the last 3 years, with FY2025 value amounting to $542000.0.

  • SRx Health Solutions' Raw Materials fell 3121.83% to $542000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $542000.0, marking a year-over-year decrease of 3121.83%. This contributed to the annual value of $542000.0 for FY2025, which is N/A changed from last year.
  • Per SRx Health Solutions' latest filing, its Raw Materials stood at $542000.0 for FY2025.
  • SRx Health Solutions' Raw Materials' 5-year high stood at $1.1 million during FY2023, with a 5-year trough of $542000.0 in FY2025.
  • Over the past 3 years, SRx Health Solutions' median Raw Materials value was $765000.0 (recorded in 2024), while the average stood at $806666.7.
  • Data for SRx Health Solutions' Raw Materials shows a peak YoY increase of 3126.68% (in 2024) and a maximum YoY decrease of 3126.68% (in 2024) over the last 5 years.
  • Over the past 3 years, SRx Health Solutions' Raw Materials (Annual) stood at $1.1 million in 2023, then crashed by 31.27% to $765000.0 in 2024, then decreased by 29.15% to $542000.0 in 2025.
  • Its Raw Materials was $542000.0 in FY2025, compared to $765000.0 in FY2024 and $1.1 million in FY2023.